Skip to main content
Caplight Logo









SPCTR

SPCTR

Private
UtrechtHealthcare & Life Scienceshttps://www.spctr.tech/

Last Round

Pre Seed

Feb 2, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

SPCTR is a healthtech company that develops AI-powered medical devices for real-time tumor margin assessment during cancer surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

medical imagingsurgical AItumor margin assessmentintraoperative imagingMedTechAI diagnosticsoptical imagingdigital pathologyreal-time diagnosticsoncology surgerysmart surgerysurgical navigationmedical deviceAI-powered surgerycomputer vision

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SPCTR Comparables

Compare SPCTR with similar companies based on industry and business-model similarity.

SPCTR comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Perimeter Medical Imaging AI Inc
84%
Xeos
81%
OncoRes Medical
81%

SPCTR Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedFeb 2, 2026

Key People

Founding team and executive leadership

Rowan Timmermans

CTO & Co-Founder

Founding Team

Wido Heeman

CEO & Founder

Founding Team

SPCTR Investors

Notable investors and investment history

SPCTR investors
InvestorRounds
Future Tech VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Monthly visitors grew 527% MoM, from 202 to 1.3K.

  • Feb 2, 2026

    Future Tech Ventures participated in the round.

Recent news

Latest coverage and updates

  • is_developingSep 3, 2026

    SPCTR is developing SPCTRone on Mar 1st '25.

SPCTR Filings

Explore SEC and related filing metadata, where available.

SPCTR filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SPCTR's valuation, stock price, and market status.

Is SPCTR a public or private company?

SPCTR is a private company.

What is the current stock price of SPCTR?

SPCTR is a private company with no public stock price. Caplight tracks SPCTR's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is SPCTR worth (valuation)?

Valuation information for SPCTR is not publicly available.

Can I buy SPCTR stock?

SPCTR shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SPCTR's last funding round?

SPCTR's most recent funding round was Pre Seed on February 2, 2026.

Who are the main investors in SPCTR?

Key investors in SPCTR include Future Tech Ventures.

Will SPCTR IPO soon?

No public IPO plans have been announced for SPCTR.

How can I track SPCTR secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SPCTR's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUtrecht
Employee Range7
Year Founded2025
Last FundingFeb 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?